Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Floxacillin

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 55Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Fusion Health Care launches favipiravir for COVID-19 treatment
    Fusion Health Care launches favipiravir for COVID-19 treatment

    17 Aug 2020

    // EXPRESSPHARMA

    https://www.expresspharma.in/covid19-updates/fusion-health-care-launches-favipiravir-for-covid-19-treatment/

    EXPRESSPHARMA
    17 Aug 2020
    Share Share
    NICE recommends antiseptics over antibiotics for impetigo
    NICE recommends antiseptics over antibiotics for impetigo

    23 Aug 2019

    // Anna Smith PHARMA TIMES

    http://www.pharmatimes.com/news/nice_recommend_antiseptics_over_antibiotics_for_impetigo_1298973

    Anna Smith PHARMA TIMES
    23 Aug 2019
    Share Share